Indegene wins 2025 BIG Innovation Award for Hyper-automated AI solution
News

Indegene wins 2025 BIG Innovation Award for Hyper-automated AI solution

Hyper-automated AI is a unified framework combining AI, ML, RPA, and NLQ to streamline data extraction, quality management, transformation, and actionable insights - all on a single platform

  • By IPP Bureau | January 18, 2025

Indegene, a digital-first life sciences commercialization company, announced that it is a winner at the 2025 BIG Innovation Awards (Product - Business Services) for ground-breaking solution called Hyper-automated AI Ecosystem for Accelerated Insights Generation.

Hyper-automated AI is a unified framework combining AI, ML, RPA, and NLQ to streamline data extraction, quality management, transformation, and actionable insights - all on a single platform.

An initiative by the Business Intelligence Group, the BIG Innovation Awards identify and recognize organizations devoted to bringing new ideas to life - honouring those dedicated to paving a new way for products, services, experiences, and community service. This recognition underscores Indegene’s commitment to pushing boundaries, solving real-world challenges, and delivering impactful solutions to customers and communities. The win is also a testimonial of Indegene’s continued efforts to help healthcare organizations be future-ready.

Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products. It is one of the very few companies globally where a medical doctor and a data scientist work next to each other to solve big, impactful problems in life sciences. And this is by design.

More than 20% of Indegene’s employees come from a medical education background and they work very closely with about 600 technologists who work on advanced artificial intelligence (AI), machine learning (ML) and other technologies.

With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies, many emerging biotech firms, and medical device companies. With over 5,000 employees worldwide, Indegene’s vast global footprint underscores its ability to scale and meet the evolving needs of the world’s leading pharma organizations across markets.

Upcoming E-conference

Other Related stories

Startup

Digitization